MedTrace Logo

MicroRNA Markers in Head and Neck Cancers

NCT04305366 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 225

Last updated 2026-02-24

No results posted yet for this study

Summary

The purpose of this study is to investigate the presence of miRNA markers in saliva, blood, FNA and tissue specimens in patients with and without head and neck cancer and evaluate whether these miRNA markers can provide prognostic or diagnostic clinical significance in the treatment of head and neck cancer patients.

Conditions

  • Squamous Cell Carcinoma of Head and Neck

Interventions

OTHER

Tissue collection

Blood draw, Fine Needle Aspiration, Saliva Swab, Tumor/tissue sample

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • University of Colorado, Denver

    lead OTHER

Principal Investigators

  • Shi-Long Lu, MD PhD · University of Colorado, Denver

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-11-16
Primary Completion
2022-12-20
Completion
2027-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04305366 on ClinicalTrials.gov